Vol 9, No 4 (2007)
Published online: 2008-02-12
Results of percutaneous transluminal angioplasty in patients with TASC A femoropopliteal lesions
Chirurgia Polska 2007;9(4):193-201.
Abstract
Background: The objective of the study was an evaluation of percutaneous transluminal angioplasty
(PTA) as a method of revascularization in TASC A femoropopliteal lesions.
Material and methods: Endovascular treatment was performed in 77 patients with symptomatic PAD because of TASC A femoropopliteal lesions. Patients qualified to undergo the procedure presented symptoms of PAD during anamnesis or physical examination. Additionally, the measurement of ankle/brachial index (ABI), Duplex Doppler examination and digital subtractive angiography were performed. PTA was carried out in all cases while in 9 (10.9%) additional stenting was required because of dissection. Results were monitored on the 3rd day after the procedure on the basis of physical examination, ABI estimation and Duplex Doppler. A follow-up was performed in a period of 6 to 18 months after the procedure.
Results: Technical success was achieved in 82 (100%) cases. Hemodynamic efficacy was obtained at a level of 92.7% on the 3rd day after PTA. A distant follow-up was performed in 71 patients (75 limbs). In 91% (68/75) of limbs unimpeded flow was confirmed. Occlusion of the vessel was detected in 5% and restenosis in 4% of cases. PTA alone is an effective method to treat TASC A femoropopliteal lesions. Stenting is indicated only if suboptimal PTA or dissection occurs.
Material and methods: Endovascular treatment was performed in 77 patients with symptomatic PAD because of TASC A femoropopliteal lesions. Patients qualified to undergo the procedure presented symptoms of PAD during anamnesis or physical examination. Additionally, the measurement of ankle/brachial index (ABI), Duplex Doppler examination and digital subtractive angiography were performed. PTA was carried out in all cases while in 9 (10.9%) additional stenting was required because of dissection. Results were monitored on the 3rd day after the procedure on the basis of physical examination, ABI estimation and Duplex Doppler. A follow-up was performed in a period of 6 to 18 months after the procedure.
Results: Technical success was achieved in 82 (100%) cases. Hemodynamic efficacy was obtained at a level of 92.7% on the 3rd day after PTA. A distant follow-up was performed in 71 patients (75 limbs). In 91% (68/75) of limbs unimpeded flow was confirmed. Occlusion of the vessel was detected in 5% and restenosis in 4% of cases. PTA alone is an effective method to treat TASC A femoropopliteal lesions. Stenting is indicated only if suboptimal PTA or dissection occurs.
Keywords: TASCangioplastypercutaneousPTAperipheralfemoropopliteal
